RFID: Marks & Spencer

At the Intelligent and Smart Packaging USA 2004 conference held in Las Vegas Jan. 27-28, I had the opportunity to listen to speeches by representatives from Nestlé, Purina, AstraZeneca, the U.S. Department of Defense, and more.

Pw 13476 Nl Pi Alr Rfid

Detailing trends in radio-frequency identification (RFID) and smart packaging was James Stafford, the head of RFID project for Marks & Spencer in the United Kingdom.

RFID leadership

As one of the first major corporations to implement broad RFID measures, Marks & Spencer continues to test new methods of tracking its inventory. To help them organize their vast product range, the company employed RFID tagging for 3.5 million returnable food produce delivery trays, as well as for its clothing products. For the food inventory, the technology will provide detailed information on stock and help staff and suppliers read that information six times faster. This will lead to reduced waste, Stafford says.

This quarter, 3.5 million trays for food transport will be produced with 13.56 Mhz read/write RFID tags, as well as 400ꯠ wheeled pallets, and all new tagged horticulture transport boxes. The tags will help identify "best before" and "use by" dates.

"2004 is what I’d like to call our ‘year of action’," Stafford says.

Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report